Clinical Trial Update: Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating angiopoietin-primed autologous peripheral blood stem cells for treatment after Acute Myocardial Infarction is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Angiopoietin-Primed Autologous Peripheral Blood Stem Cell

Snippet

Sponsor: Seoul National Hospital | Conditions: Acute Myocardial Infarction | Phase 3 | Status: RECRUITING